Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Johnson and Johnson
McKinsey
Moodys
Dow

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Patent: 6,132,976

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,132,976
Title: Immunoassays for the measurement of collagen denaturation and cleavage in cartilage
Abstract:The present invention relates to a method for detecting cartilage degradation in a biological sample by identifying the presence of unwound type II collagen in the biological sample, said method comprising: contacting the biological sample with a monoclonal antibody which does not bind to native helical collagen but which does bind to an epitope on unwound type II collagen chains or fragments thereof, wherein said epitope has the following sequence (SEQ ID NO: 4): detecting the presence of the bound monoclonal antibody. The present invention also relates to a method for detecting collagenase induced cartilage degradation in a biological sample by identifying the presence of an epitope on type II collagen which only becomes detectable following cleavage of said collagen by collagenase, said method comprising: contacting the biological sample with a monoclonal antibody which binds to said epitope on type II collagen chains or fragments thereof containing said epitope; and detecting the presence of said monoclonal antibody bound to the type II collagen and fragments.
Inventor(s): Poole; Anthony Robin (Baie d\'Urfe, CA), Hollander; Anthony Peter (Greystones, GB), Billinghurst; R. Clark (Fort Collins, CO)
Assignee: Shriners Hospitals for Children (Tampa, FL)
Application Number:09/010,999
Patent Claims:see list of patent claims

Details for Patent 6,132,976

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Smith & Nephew, Inc. SANTYL collagenase Ointment 101995 1965-06-04 ⤷  Try it Free 2012-12-04
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Harvard Business School
Merck
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.